165 related articles for article (PubMed ID: 7459208)
1. The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.
El Kappany H; Chopra C; Nigam VN; Brailovsky CA; Elhilali M
Br J Cancer; 1980 Nov; 42(5):703-11. PubMed ID: 7459208
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant immunotherapy of N-[4(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder tumors.
Ibraheim EH; El Kappany H; Nigam VN; Brailovsky CA; Madarnas P; Elhilali MM
Anticancer Res; 1984; 4(3):209-13. PubMed ID: 6465859
[TBL] [Abstract][Full Text] [Related]
3. Combination of 60Co gamma-radiation, misonidazole, and maltose tetrapalmitate in the treatment of Dunning prostatic tumor in the rat.
Pageau R; Nigam VN; Fisher GJ; Brailovsky CA; Fathi MA; Corcos J; Tahan TW; Elhilali MM
Int J Radiat Oncol Biol Phys; 1985 Aug; 11(8):1483-7. PubMed ID: 4019272
[TBL] [Abstract][Full Text] [Related]
4. Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
Ibrahiem EH; Nigam VN; Brailovsky CA; Backman BD; Elhilali MM
Cancer Res; 1984 Feb; 44(2):536-42. PubMed ID: 6537897
[TBL] [Abstract][Full Text] [Related]
5. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
Bartlett GL; Kreider JW; Purnell DM
Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633
[TBL] [Abstract][Full Text] [Related]
7. Regression of a hamster melanoma with intralesional Corynebacterium granulosum.
Paslin D
Br J Dermatol; 1976 Jun; 94(6):639-44. PubMed ID: 949459
[TBL] [Abstract][Full Text] [Related]
8. Combination chemo-immunotherapy with adriamycin in experimental tumor systems.
Tagliabue A; Polentarutti N; Vecchi A; Mantovani A; Spreafico F
Eur J Cancer (1965); 1977 Jul; 13(7):657-65. PubMed ID: 598392
[No Abstract] [Full Text] [Related]
9. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
Woodruff MF; Whitehead VL; Speedy G
Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
[TBL] [Abstract][Full Text] [Related]
10. The effect of maltose tetrapalmitate (MTP) on prostate cancer growth in vivo and in vitro.
Nguyen NM; Lehr JE; Shelley CI; Andersen JC; Pienta KJ
Anticancer Res; 1993; 13(6A):2053-8. PubMed ID: 7507653
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of intratumoral immunostimulants in the treatment of a transplantable rat mammary carcinoma.
Willmott N; Austin EB; Pimm MV; Baldwin RW
Eur J Cancer (1965); 1981 Apr; 17(4):397-405. PubMed ID: 7308253
[No Abstract] [Full Text] [Related]
12. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
13. Failure of preoperative C. parvum vaccine to modify secondary disease following excision of two non-immunogenic murine carcinomas.
Hewitt HB; Blake ER
Br J Cancer; 1978 Aug; 38(2):219-23. PubMed ID: 698036
[TBL] [Abstract][Full Text] [Related]
14. The use of immunopotentiators in malaria.
Strickland GT; Hunter KW
Int J Nucl Med Biol; 1980; 7(2):133-40. PubMed ID: 6772589
[No Abstract] [Full Text] [Related]
15. Effect of the combination of Corynebacterium parvum and levamisole on murine tumors.
Anaclerio A; Conti G; Moras ML; Barale C; Spreafico F
Eur J Cancer (1965); 1977 Dec; 13(12):1451-53. PubMed ID: 413718
[No Abstract] [Full Text] [Related]
16. Evaluation of cortisone-heparin and cortisone-maltose tetrapalmitate therapies against rodent tumors. I. Biological studies.
Benrezzak O; Madarnas P; Pageau R; Nigam VN; Elhilali MM
Anticancer Res; 1989; 9(6):1883-7. PubMed ID: 2627134
[TBL] [Abstract][Full Text] [Related]
17. Effects of single and combined maltose tetrapalmitate immunotherapy, cyclophosphamide chemotherapy and radiotherapy on ethyl carbamate accelerated primary lung cancer in A/J mice.
Benrezzak O; Madarnas P; Pageau R; Nigam VN
In Vivo; 1988; 2(2):159-65. PubMed ID: 2979834
[TBL] [Abstract][Full Text] [Related]
18. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
Kreider JW; Bartlett GL; Boyer CM; Purnell DM
Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment of rodent fibrosarcoma by radiotherapy and immune adjuvant.
Moroson H; Rotman M; Schechter M
Int J Radiat Oncol Biol Phys; 1976; 1(3-4):267-74. PubMed ID: 786964
[No Abstract] [Full Text] [Related]
20. [Treatment of solid tumours by intratumoral injection of immunostimulants].
Salomon JC; Lynch N
Ann Immunol (Paris); 1977; 128(1-2):125-7. PubMed ID: 322574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
